Nexon Pharmasp. z o.o. + limited partnership

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-02-20
Limited partner contribution
20,000.00 PLN
Activity description

Nexon Pharma offers dietary supplements supporting immunity, including MEDIPROLAC IMMUNO, MEDIPROLAC IBEES, and MEDIPROLAC products for children in capsules and drops. Its range also includes vitamins C, D3 + K2, D3, B12 and B Complex, as well as Euphrasia Świetlik.

Registered address
ul. Chełmżyńska 249, 04-458 Warszawa, Poland
Website
nexonpharma.pl
Email
Phone
Social media
Electronic delivery address
AE:PL-91671-18219-IUBDD-18

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 84 days late).

  • 202523/06/2026
  • 202427/06/2025
  • 202321/06/2024
  • 202228/06/2023
  • 202107/10/2022
  • 202011/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 631.78kMedianUSD 287.80kAverageUSD 4.90m
Net profit
This companyUSD 61.14kMedianUSD 12.59kAverageUSD 208.64k
Operating costs
This companyUSD 556.87kMedianUSD 272.78kAverageUSD 4.48m
Assets
This companyUSD 344.53kMedianUSD 224.38kAverageUSD 5.76m

Industry

Offer

  • Eye drops
  • Immune support supplements
  • Vitamin supplements
  • Cold remedies
  • Sleep aids
  • Cholesterol supplements
  • Digestive health supplements

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Analytics

Trademarks

Nexon Pharma holds 4 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2017.

MarkNumberClassesStatusProtected until
LAXATIVZ.5028905Protected Jul 29, 2029
SYROP z porostem islandzkim ISLANDZKI medic+Z.5009905Protected Jun 11, 2029
LipiRedox K(word)Z.4901545Protected Sep 5, 2028
NP NEXON PHARMA EUPHRASIA ŚWIETLIKZ.4741035Protected Jul 13, 2027
Mark without a word element(figurative)Z.5009935Refused –
MarkProtected until
LAXATIVJul 29, 2029
SYROP z porostem islandzkim ISLANDZKI medic+Jun 11, 2029
LipiRedox K(word)Sep 5, 2028
NP NEXON PHARMA EUPHRASIA ŚWIETLIKJul 13, 2027
Mark without a word element(figurative)–

Partners

Partners
Sławomir Radosław Bernaciakage 55
Marcin Adam Grduszakage 55
Marzena Teresa Idzikowskaage 56
Inpharm Support sp. z o.o.
Nexon Pharma Sp. z o.o.
Agata Matylda Zalega Bernaciakage 53

Manner of representation

The company is represented by the general partner NEXON PHARMA limited liability company.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-03-02.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Warszawskie Zakłady Sprzętu OrtopedycznegoS.A.
Tech-Med Technika Medyczna B.Wójciksp. j.
Metzer Medizin- Und Industrietechniksp. z o.o.
Optyk Plussp. z o.o.
Endotradesp. z o.o.
Implaisp. z o.o.
Salon Ortopedyczny Or-Techsp. z o.o.
EndolinkS.A.
Your Labsp. z o.o.
PhilabsS.A.

FAQ

Last updated: 2026-06-23